|

Terelizumab (aka Tislelizumab) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1

Indications

  • Rectal Cancer1
  • Radiotherapy1
  • Immunotherapy1
  • Chemotherapy Effect1
  • Gastric Cancer1

Other1 trial

Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.